Encompass Health (EHC) Stock Forecast & Price Target

EHC price $129.19 +7.11 +5.82%

Ticker
EHC
Price
$129.19
Change
+7.11 +5.82%
Market cap ?
$12.75B
P/E ?
18.81
Forward P/E ?
21.14
Dividend yield ?
0.64%
Beta ?
0.60
Sector
Healthcare
Industry
Medical - Care Facilities
Stocklytics score
43
Value
29
Quality
52
Growth
49

Stocklytics score rationale: value 29, quality 52, growth 49.

Financials

2016201720182019202020212022202320242025
3642600000391390000042773000004605000000356630000040149000004348600000480120000053732000005935200000

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or…

Forecast

Consensus Buy from 13 analysts. Average price target $150.20, +16.3% versus the current price. Low $144.00. High $155.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $150.20 for Encompass Health (EHC), 17.0% above the current price of $128.34. Of 13 analysts covering the stock, 13 rate it Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

EHC price target

12-month price target
Low$144.00
Average$150.20
High$155.00

The average is 17.0% above the current price of $128.34.

Is Encompass Health a buy or sell?

Of 13 analysts, 13 rate Encompass Health Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Encompass Health earnings and revenue forecast

Analyst averages on file: 2026, EPS $6.11, revenue $6.46 billion. 2027, EPS $6.68, revenue $6.99 billion.

EHC score and fair value

The Stocklytics Score for EHC is 43 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

EHC forecast FAQs

What is the EHC price target?

$150.20 average, with a published range of $144.00 to $155.00.

Is Encompass Health a buy or sell?

The consensus is Buy from 13 analysts. This is not a recommendation.

What is the Encompass Health stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is $6.11. The average revenue estimate is $6.46 billion.

What will EHC be worth in 2030?

No reliable forecast exists that far out.

When is Encompass Health's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Encompass Health · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Encompass Health (EHC) Stock Forecast & Price Target

EHC$129.19+7.11 +5.82%

$12.75B

Market Cap

18.81

P/E

21.14

Forward P/E

43

Score

Price History